The data on an inactivation scheme for the agent of porcine pasteurellosis, development of the inactivated vaccine and ratio of the antigen and adjuvant are presented. As a result of the realized research it has been established, that for Pasteurella inactivation it is necessary to use formalin in concentration of 0,5% at an exposition at 1 hour. At vaccine producing it is necessary to apply an antigene parity to adjuvant 50:50 as the received vaccine does not concede on all parameters to the vaccine in which a parity of components accordingly 40:60. Thus received vaccine possesses smaller reactogenicity and more adjuvanticity. One of the basic conditions of reception of homogeneous stable emulsion is warming up of water and oil phases to temperature 30 deg С (+/-1 deg С). | Представлены сведения о разработке схемы инактивации возбудителя для изготовления инактивированной вакцины, а также о выборе соотношения антигена и адъюванта. В результате проведенных исследований было установлено, что для инактивации пастерелл следует использовать формалин в концентрации 0,5% при экспозиции в 1 час. При изготовлении вакцины необходимо применять соотношение антигена к адъюванту 50:50, так как полученная вакцина не уступает по всем параметрам вакцине, в которой соотношение компонентов соответственно 40:60. При этом полученная вакцина обладает меньшей реактогенностью и большей иммуногенностью. Одним из основных условий получения однородной стабильной эмульсии является подогревание водной и масляной фаз до температуры 30 deg С (+/-1 deg С).

Research of immune activity of an experimental series of inactivated vaccine against swine pasteurellosis (Pasteurella) with application of adjuvants of Sepptic Montanida ISA 70 and Montanida ISA 206 was realized in the conditions of the Republic of Belarus. In the capacity of water phase there were used serovars A, B, and D Pasteurella multocida. Research results proved the possibility of application of adjuvants of Sepptic company for the development of vaccine against pasteurellosis. The vaccine with the presented adjuvants after its application did not cause after-trouble effects. In course of immunization there was noted the formation long-lived continuous immunity that was proved by high titres of specific anti-bodies in blood serum in all experimental groups of piglets. Single application of the proposed vaccine in doses 2 or 3 ml per animal proved to be effective. Also it was efficient to apply it twice in doses 1 and 2 ml per animal. For the vaccine production it was proposed to use adjuvant Montanida ISA 206 which did not have high reactogenicity

In the conditions of the Republic of Belarus there was realized a morphological study of bone marrow aspirates at different terms chicken of immunization against Gumboro disease which made it possible to analyze the state of immune system for the objective evaluation of immunological status. Research results showed that chicken immunization with a national liquid chick embryo viral vaccine produced on the basis of KMIehV-13 strain against Gumboro disease (infectious bursal disease) promoted the development of immunomorphological remodeling of bone marrow. Application of immunostimulants Alveozan and Nukleovit for poultry vaccination caused more expressed changes revealing in statistically reliable increasing of total number of myeloblastic cells in the majority of cases by means of increasing of immature cells, and then mature cells of granulocytic series, as well as quantity of lymphocytes and plasmacytes